These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8731307)

  • 41. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.
    Cohen M
    J Thromb Thrombolysis; 2001 Apr; 11(2):171-4. PubMed ID: 11406733
    [No Abstract]   [Full Text] [Related]  

  • 42. Assessment of low-molecular-weight heparin trials in cardiology.
    Shulman RI
    Pharmacol Ther; 2000 Jul; 87(1):1-9. PubMed ID: 10924738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A report on thrombolytic therapy in cardiology].
    Sanz Romero G; Cabadés O'Callaghan A; Fernández Palomeque C; López Bescós L; Marín Huerta E; Pajarón López A; del Río del Busto A
    Rev Esp Cardiol; 1993 Nov; 46(11):698-710. PubMed ID: 8290770
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of low-molecular-weight heparin in cardiovascular diseases.
    Mukherjee D; Topol EJ
    Prog Cardiovasc Dis; 2002; 45(2):139-56. PubMed ID: 12411975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Present treatment options for unstable angina and non-Q-wave myocardial infarction.
    Lairikyengbam SK; Davies AG; Anderson MH
    QJM; 2001 Jan; 94(1):5-11. PubMed ID: 11161130
    [No Abstract]   [Full Text] [Related]  

  • 46. Low molecular weight heparins in acute ischaemic syndromes.
    White HD; Ellis CJ; French JK
    Aust N Z J Med; 1998 Aug; 28(4):555-7. PubMed ID: 9777139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of action and pharmacology of unfractionated heparin.
    Hirsh J; Anand SS; Halperin JL; Fuster V
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1094-6. PubMed ID: 11451734
    [No Abstract]   [Full Text] [Related]  

  • 48. LMWH in acute myocardial infarction.
    Dutta AL
    Indian Heart J; 2011; 63(1):84-8. PubMed ID: 23189870
    [No Abstract]   [Full Text] [Related]  

  • 49. [Low-molecular-weight heparins in unstable angina and non-Q-wave myocardial infarction].
    Rubio-Terrés C; Pajuelo F; Margalet I
    Med Clin (Barc); 2001 May; 116(16):638-9. PubMed ID: 11412657
    [No Abstract]   [Full Text] [Related]  

  • 50. [Heparin in heart failure and unstable angina pectoris].
    Górski J; Dmochowska-Wróblewska W
    Kardiol Pol; 1993 Mar; 38(3):229-31. PubMed ID: 8231002
    [No Abstract]   [Full Text] [Related]  

  • 51. Advances in unstable angina: the role of low molecular weight heparins. Introduction and Chairmen's summary.
    Braunwald E; Gurfinkel E
    Heart; 1999 Sep; 82 Suppl 1(Suppl 1):I1, I21. PubMed ID: 10469668
    [No Abstract]   [Full Text] [Related]  

  • 52. Heparin in acute coronary syndromes.
    Peverill RE
    Lancet; 2000 Aug; 356(9229):593-4. PubMed ID: 10950255
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. A panel discussion with audience participation.
    Chesebro JH; Verheugt FW; Kontny F; Fry ET; Wallentin L; Camm AJ; Bechtold H
    Clin Cardiol; 2001 Mar; 24(3 Suppl):I20-2. PubMed ID: 11286311
    [No Abstract]   [Full Text] [Related]  

  • 54. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.
    Hirsh J; Warkentin TE; Shaughnessy SG; Anand SS; Halperin JL; Raschke R; Granger C; Ohman EM; Dalen JE
    Chest; 2001 Jan; 119(1 Suppl):64S-94S. PubMed ID: 11157643
    [No Abstract]   [Full Text] [Related]  

  • 55. New approaches to diagnosis and management of unstable angina and non-ST segment elevation myocardial infarction: controversial data.
    Borja J; Paz MA; Olivella P
    Arch Intern Med; 2002 Feb; 162(4):485-6. PubMed ID: 11863490
    [No Abstract]   [Full Text] [Related]  

  • 56. [Unstable angina pectoris: the catheter can wait].
    Verheugt FW
    Ned Tijdschr Geneeskd; 1994 Sep; 138(37):1845-50. PubMed ID: 7935919
    [No Abstract]   [Full Text] [Related]  

  • 57. Low-molecular weight heparins in coronary artery disease.
    Hunt D
    Curr Atheroscler Rep; 2001 Mar; 3(2):163-8. PubMed ID: 11177661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low molecular weight heparins in acute coronary syndromes.
    Fox KA
    Eur Heart J; 1998 Jun; 19(6):817-9. PubMed ID: 9651699
    [No Abstract]   [Full Text] [Related]  

  • 59. Fraxiparin for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Amann FW; Neuenschwander C; Meyer BJ
    Semin Thromb Hemost; 1993; 19 Suppl 1():160-3. PubMed ID: 8395720
    [No Abstract]   [Full Text] [Related]  

  • 60. Aspirin versus heparin in the acute phase of unstable angina.
    Moise A; Roos M
    Circulation; 1994 Aug; 90(2):1107. PubMed ID: 8044926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.